Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy
ClinicalTrials.gov study NCT02579616. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer
ClinicalTrials.gov study NCT01839487. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00267020. IPD Sharing: Not stated. Countries: 1. Publications: 1.
QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00630552. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT01342172. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT01844817. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00924209. IPD Sharing: NO. Countries: 2. Publications: 3.
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
ClinicalTrials.gov study NCT00948935. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00503906. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01041781. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients
ClinicalTrials.gov study NCT00449033. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01746979. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00400803. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00662129. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT01287624. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients
ClinicalTrials.gov study NCT02812992. IPD Sharing: NO. Countries: 1. Publications: 1.
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
ClinicalTrials.gov study NCT03257033. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors
ClinicalTrials.gov study NCT01428427. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent Lymphoma
ClinicalTrials.gov study NCT00954005. IPD Sharing: Not stated. Countries: 1. Publications: 1.
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
ClinicalTrials.gov study NCT00040183. IPD Sharing: Not stated. Countries: 17. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.